900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri)	A component that is no longer current, useful, appropriate or acceptable.
pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina)	A component that is no longer current, useful, appropriate or acceptable.
pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube)	A component that is no longer current, useful, appropriate or acceptable.
pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary)	A component that is no longer current, useful, appropriate or acceptable.
pT2 category	A component that is no longer current, useful, appropriate or acceptable.
pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Organ confined (prostate)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor extends to the soft tissues (nasopharynx)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades duodenal wall (ampulla of Vater)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis (renal pelvis and ureter)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis propria (appendix)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis propria (colon/rectum)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis propria (esophagus)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis propria (small intestine)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades muscularis propria or subserosa (stomach)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 8 cm in greatest dimension (bone)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung)	A component that is no longer current, useful, appropriate or acceptable.
pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	A component that is no longer current, useful, appropriate or acceptable.
pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube)	A component that is no longer current, useful, appropriate or acceptable.
pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri)	A component that is no longer current, useful, appropriate or acceptable.
pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix)	A component that is no longer current, useful, appropriate or acceptable.
pT2a category	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor invades muscularis propria (stomach)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor invades superficial muscle (inner half) (urinary bladder)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue)	A component that is no longer current, useful, appropriate or acceptable.
pT2a: Unilateral, one-half of one lobe or less (prostate)	A component that is no longer current, useful, appropriate or acceptable.
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	A component that is no longer current, useful, appropriate or acceptable.
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri)	A component that is no longer current, useful, appropriate or acceptable.
pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube)	A component that is no longer current, useful, appropriate or acceptable.
pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix)	A component that is no longer current, useful, appropriate or acceptable.
pT2b category	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor invades choroid focally (retinoblastoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor invades deep muscle (outer half) (urinary bladder)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor invades subserosa (stomach)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue)	A component that is no longer current, useful, appropriate or acceptable.
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate)	A component that is no longer current, useful, appropriate or acceptable.
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	A component that is no longer current, useful, appropriate or acceptable.
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube)	A component that is no longer current, useful, appropriate or acceptable.
pT2c category	A component that is no longer current, useful, appropriate or acceptable.
pT2c: Bilateral disease (prostate)	A component that is no longer current, useful, appropriate or acceptable.
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma)	A component that is no longer current, useful, appropriate or acceptable.
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	A component that is no longer current, useful, appropriate or acceptable.
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri)	A component that is no longer current, useful, appropriate or acceptable.
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina)	A component that is no longer current, useful, appropriate or acceptable.
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix)	A component that is no longer current, useful, appropriate or acceptable.
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube)	A component that is no longer current, useful, appropriate or acceptable.
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva)	A component that is no longer current, useful, appropriate or acceptable.
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)	A component that is no longer current, useful, appropriate or acceptable.
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary)	A component that is no longer current, useful, appropriate or acceptable.
pT3 category	A component that is no longer current, useful, appropriate or acceptable.
pT3: Discontinuous tumors in the primary bone site (bone)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Extraprostatic extension (prostate)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands)	A component that is no longer current, useful, appropriate or acceptable.
pT3: Tumor invades adventitia (esophagus)	A component that is no longer current, useful, appropriate or acceptable.

Start Previous Page 1408 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)